Cytosorbents Corporation

CTSO·NASDAQ·$0.46Share Price as of 11/2·$29MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/13/26 10-K/AFY 202504/15/26 10-KFY 202503/30/26 10-QQ3 ended 09/30/2511/13/25

Disclosures

8-KCurrent report09/23/26 8-KCurrent report09/08/26 8-KCurrent report08/14/26 8-KCurrent report08/07/26 8-KCurrent report08/06/26

Prospectuses and Registrations

424B5Prospectus supplement12/09/24 FWPFree writing prospectus12/09/24 424B5Prospectus supplement10/01/24 S-3/AShelf registration (amended)09/26/24 S-8Registration of securities for employees08/16/24

Proxies

DEF 14ADefinitive proxy06/25/26 DEFA14AAdditional proxy materials06/25/26 PRE 14APreliminary proxy06/11/26 DEF 14ADefinitive proxy04/23/25 DEFA14AAdditional proxy materials04/23/25

Ownership

Form 4Insider transaction09/16/26 Form 4Insider transaction09/16/26 Form 4Insider transaction09/16/26 Form 4Insider transaction09/09/26 Form 4Insider transaction06/16/26

Other

ARSAnnual report to shareholders06/25/26 ARSAnnual report to shareholders04/23/25 EFFECTRequest for effectiveness09/30/24 CORRESPCorrespondence with the SEC09/27/24 UPLOADLetter from the SEC07/31/24